Ewing’s U: Dr. Loeb on DFMO for Ewing's Sarcoma

In November, we talked to David Loeb, MD, PhD about his promising research on DFMO for Ewing Sarcoma. DFMO is an FDA Approved Drug for African Sleeping Sickness, a parasitic disease transmitted by Tsetse flies in sub-Saharan Africa. This unlikely drug is currently being used to reduce neuroblastoma recurrences in a clinical trial and is up for FDA approval. 

Dr. Loeb shared the results of his research in animal models and talked about the potential of this drug for Ewing Sarcoma.